Specifically, this can include the big four: Nausea Diarrhea Vomiting Constipation Also relatively common are abdominal pain and dyspepsia (discomfort or pain in the upper abdomen after eating or drinking)
Yes, costs for five of the GLP-1 drugs (Ozempic, Mounjaro, Wegovy, Zepbound, and Saxenda) topped $300 million in 2024
In its initial announcements, CMS indicated that the GLP-1 Bridge program would run from July 1, 2026, through the end of the year, with the BALANCE Model beginning in January 2027
below body temperature, at about 4 C
While microdosing GLP-1s may be beneficial for a variety of reasons for certain individuals, the growing interest in microdosing GLP-1s can at least in part be tied to the significant metabolic shifts women experience during perimenopause and menopause
Pandey A, Shah SJ, Butler J, et al